vs
Karman Holdings Inc.（KRMN）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Karman Holdings Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.9倍（$134.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.7%，领先378.3%），Karman Holdings Inc.同比增速更快（47.4% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 27.3%）
Karman Holdings是一家美国航天与防务系统制造商，总部位于加利福尼亚州亨廷顿海滩，当前估值约40亿美元，近期已完成首次公开发行，专注为航天及国防领域提供相关系统产品及配套服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KRMN vs RIGL — 直观对比
营收规模更大
KRMN
是对方的1.9倍
$69.8M
营收增速更快
KRMN
高出26.2%
21.2%
净利率更高
RIGL
高出378.3%
5.7%
两年增速更快
RIGL
近两年复合增速
27.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $134.5M | $69.8M |
| 净利润 | $7.7M | $268.1M |
| 毛利率 | 39.9% | 91.5% |
| 营业利润率 | 15.7% | 33.2% |
| 净利率 | 5.7% | 384.0% |
| 营收同比 | 47.4% | 21.2% |
| 净利润同比 | 358.3% | 1769.2% |
| 每股收益（稀释后） | $0.06 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRMNRIGL
| Q4 25 | $134.5M | $69.8M | ||
| Q3 25 | $121.8M | $69.5M | ||
| Q2 25 | $115.1M | $101.7M | ||
| Q1 25 | $100.1M | $53.3M | ||
| Q4 24 | $91.2M | $57.6M | ||
| Q3 24 | $86.0M | $55.3M | ||
| Q2 24 | $85.0M | $36.8M | ||
| Q1 24 | $83.0M | $29.5M |
净利润KRMNRIGL
| Q4 25 | $7.7M | $268.1M | ||
| Q3 25 | $7.6M | $27.9M | ||
| Q2 25 | $6.8M | $59.6M | ||
| Q1 25 | $-4.8M | $11.4M | ||
| Q4 24 | $1.7M | $14.3M | ||
| Q3 24 | $4.3M | $12.4M | ||
| Q2 24 | $4.6M | $-1.0M | ||
| Q1 24 | $2.1M | $-8.2M |
毛利率KRMNRIGL
| Q4 25 | 39.9% | 91.5% | ||
| Q3 25 | 41.0% | 93.2% | ||
| Q2 25 | 40.9% | 95.6% | ||
| Q1 25 | 39.4% | 91.7% | ||
| Q4 24 | 38.1% | 89.9% | ||
| Q3 24 | 39.3% | 85.5% | ||
| Q2 24 | 40.7% | 92.4% | ||
| Q1 24 | 34.9% | 93.1% |
营业利润率KRMNRIGL
| Q4 25 | 15.7% | 33.2% | ||
| Q3 25 | 17.9% | 40.9% | ||
| Q2 25 | 17.5% | 60.1% | ||
| Q1 25 | 10.0% | 23.9% | ||
| Q4 24 | 15.8% | 28.9% | ||
| Q3 24 | 20.2% | 25.4% | ||
| Q2 24 | 21.5% | 1.2% | ||
| Q1 24 | 16.3% | -23.6% |
净利率KRMNRIGL
| Q4 25 | 5.7% | 384.0% | ||
| Q3 25 | 6.3% | 40.2% | ||
| Q2 25 | 5.9% | 58.6% | ||
| Q1 25 | -4.8% | 21.5% | ||
| Q4 24 | 1.8% | 24.9% | ||
| Q3 24 | 5.0% | 22.5% | ||
| Q2 24 | 5.4% | -2.8% | ||
| Q1 24 | 2.6% | -27.9% |
每股收益（稀释后）KRMNRIGL
| Q4 25 | $0.06 | $14.11 | ||
| Q3 25 | $0.06 | $1.46 | ||
| Q2 25 | $0.05 | $3.28 | ||
| Q1 25 | $-0.04 | $0.63 | ||
| Q4 24 | $0.01 | $0.82 | ||
| Q3 24 | $0.03 | $0.70 | ||
| Q2 24 | $0.03 | $-0.06 | ||
| Q1 24 | $0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $382.7M | $391.5M |
| 总资产 | $1.1B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KRMNRIGL
| Q4 25 | $34.0M | $155.0M | ||
| Q3 25 | $18.7M | $137.1M | ||
| Q2 25 | $27.4M | $108.4M | ||
| Q1 25 | $113.7M | $77.1M | ||
| Q4 24 | $11.5M | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务KRMNRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益KRMNRIGL
| Q4 25 | $382.7M | $391.5M | ||
| Q3 25 | $369.1M | $117.6M | ||
| Q2 25 | $361.5M | $81.9M | ||
| Q1 25 | $348.9M | $18.6M | ||
| Q4 24 | $196.0M | $3.3M | ||
| Q3 24 | $194.1M | $-14.6M | ||
| Q2 24 | $189.6M | $-29.9M | ||
| Q1 24 | $184.8M | $-31.7M |
总资产KRMNRIGL
| Q4 25 | $1.1B | $513.6M | ||
| Q3 25 | $968.1M | $242.5M | ||
| Q2 25 | $953.9M | $206.7M | ||
| Q1 25 | $875.4M | $176.0M | ||
| Q4 24 | $774.0M | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比KRMNRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $4.0M | — |
| 自由现金流率自由现金流/营收 | 3.0% | — |
| 资本支出强度资本支出/营收 | 3.5% | — |
| 现金转化率经营现金流/净利润 | 1.13× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-42.5M | — |
8季度趋势，按日历期对齐
经营现金流KRMNRIGL
| Q4 25 | $8.7M | $22.0M | ||
| Q3 25 | $131.0K | $24.0M | ||
| Q2 25 | $-17.4M | $30.5M | ||
| Q1 25 | $-13.6M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K | ||
| Q1 24 | $3.1M | $-5.0M |
自由现金流KRMNRIGL
| Q4 25 | $4.0M | — | ||
| Q3 25 | $-6.8M | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-18.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.5M | — |
自由现金流率KRMNRIGL
| Q4 25 | 3.0% | — | ||
| Q3 25 | -5.6% | — | ||
| Q2 25 | -18.2% | — | ||
| Q1 25 | -18.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.8% | — |
资本支出强度KRMNRIGL
| Q4 25 | 3.5% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.9% | — |
现金转化率KRMNRIGL
| Q4 25 | 1.13× | 0.08× | ||
| Q3 25 | 0.02× | 0.86× | ||
| Q2 25 | -2.55× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRMN
| Tactical Missile And Integrated Defense Systems | $50.5M | 38% |
| Hypersonic And Strategic Missile Defense | $48.4M | 36% |
| Space And Launch | $35.7M | 27% |
RIGL
暂无分部数据
